Jammu ,jun 14
SS Innovations, the developer of India’s first Indigenous surgical robotic system- SSI Mantra, dedicated to making advanced robotic surgeries cost-effective and accessible to a global population, today launched SSI Mantra 3, which is the next generation, most advanced version of the Mantra surgical robot system. Alongside, it has achieved a historic feat in Indian medical science by completing the Nation’s maiden human trial in telesurgery, signifying a monumental leap in surgical robotics. The launch of SSI Mantra 3 underlines SS Innovations’ commitment to revolutionising healthcare by providing cutting-edge technology at affordable prices.The new SSI Mantra 3 is highly advanced and is designed to enhance surgical precision, efficiency, and patient outcomes by integrating the latest advancements in robotic surgery, featuring 5 slimmer robotic arms and an immersive 3D HD headset which provides surgeons with unmatched optics and a vision cart that provides 3D 4K vision to the entire team for precision and control. Additionally, the cost-effective pricing of SSI Mantra 3 aims to make advanced surgical technologies more accessible to healthcare institutions across all regions of India and the world. In a momentous stride forward, SS Innovations has successfully conducted India’s first human trial in telesurgery using the SSI Mantra Surgical Robot. This groundbreaking, flawless surgery was a robotic cholecystectomy that took place between the World Laparoscopy Hospital and the SSI Headquarters over a distance of 5 kilometres using the seamless connectivity of Airtel’s fiberoptic network with no perceptible delay. The telesurgery trial signifies a major step forward in providing quality healthcare to remote areas, further aligning with the Make in India initiative by showcasing Indigenous innovation on a global stage. In a notable step forward, Dr. Fredric Moll, widely regarded as the father of surgical robotics, and the visionary founder of Intuitive Surgical, has joined SS Innovations International Inc., as a Board Member and Vice Chairman. Dr. Moll has been a pivotal force in advancing robotic surgery and contributed significantly to the development of various groundbreaking robotic technologies that have contributed to the evolution of robotics in medicine. Dr. Moll’s addition to the leadership team of SS Innovations underscores the organisation’s commitment to excellence and innovation in the medical device industry.
Founder, Chairman and CEO, of SS Innovations, Dr Sudhir Srivastava, pioneer in robotic cardiac surgery and the brain behind the SSI Mantra System, popularly known as the Father of Surgical Robotics in India, reflects on this milestone: “Today marks a significant moment in our journey towards revolutionising and decentralising excellence in the healthcare industry. With the launch of SSI Mantra 3 and the successful completion of India’s first human trial in soft tissue telesurgery, we reaffirm our commitment to driving advanced innovation and accessibility in robotic surgeries. These achievements underline our belief in the power of our indigenous technology to transform healthcare across the globe. We are proud to contribute to the Make in India initiative and remain dedicated to advancing the boundaries of surgical excellence.”
Commenting on this milestone, Dr. Fredric Moll, Father of Surgical Robotics, and Founder of Intuitive Surgical, said: “I would like to extend my heartfelt congratulations to Dr. Srivastava and the entire SSI team on the successful launch of SSI Mantra 3. Achieving this milestone in less than five months is truly commendable. I am excited to get more involved with SSI, joining as Board Member and Vice Chairman. The Mantra 3 system is powerful enough that broadens the reach of surgeons and enhances their efficiency.
